Dear Local Health Departments,
On Wednesday, Aug. 27, 2025, FDA approved the updated 2025-2026 COVID-19 vaccines and rescinded Emergency Use Authorizations (EUA) for previously authorized COVID-19 vaccines.
Immunization Provider Memos and Communications
"NCIP releases a 30-min Childhood Vaccine Education Webinar with strategies for addressing vaccine hesitancy in families."
This memo is to inform North Carolina Immunization Program (NCIP) providers of the availability of influenza vaccine and the ordering process for the 2025-2026 respiratory season. Please take time to carefully review this memo in full.
"NC COVID-19 2024–25 vaccine orders: Pfizer by 8/7/25, Moderna by 8/24/25; use all doses before expiration."
"NCIP announces additional 317 funds for LHDs to provide MMR vaccine to uninsured and underinsured adults until September or while supplies last."
The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.
We are writing to inform you of several changes to the Vaccines for Children (VFC) program policies that may affect your practice, effective July 1, 2025.
This email is to inform you of an important update to share regarding measles reporting, testing, and vaccination.